IMMUNITYBIO RECEIVES UNITED ARAB EMIRATES (UAE) MARKETING AUTHORIZATION FOR ANKTIVA® ACROSS BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER FOR CIS AND PAPILLARY DISEASE AND METASTATIC NON-SMALL CELL LUNG CANCER

Reuters · 1d ago

Please log in to view news